Stock screenerAll disclosures →
EDGAR →
NTLA
Conviction 72HealthcareScan · Fri, Jun 26, 2026NTLA$16.65+3.87%
ResistanceSupportVol 14Vol MA14 7.37M
Mar 27Apr 15May 4May 20Jun 9Jun 26
WSB mentions · 24h changelatest +100.00%· 2 mentions
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price16.65
Change+3.87%
Gap-1.22%
Rel volume1.30×
Avg volume6.82M
Avg $ vol97.96M
SMA 2014.24
SMA 5013.92
SMA 20013.57
Price vs 50+19.65%
Price vs 200+22.72%
MA stackbullish
50/200 cross—
Supertrendup · 12.81
RSI (14)65
MACD hist0.30
MACD crossbull · 8d
Stoch %K / %D94 / 85
ADX (14)26
+DI / −DI32 / 12
RSI divergence—
MACD divergence—
ATR %+7.06%
ADR %8.40%
52w high27.98
52w low8.04
From 52w high-40.49%
Above 52w low+107.09%
New 52w highNo
SqueezeOff
Bollinger width37.60%
%B0.95
Donchian pos94.16%
Donchian high16.95
Donchian low11.81
AVWAP (52w high)13.00
vs AVWAP high+28.09%
AVWAP (52w low)12.85
vs AVWAP low+29.62%
OBV trendUp
Chaikin MF (20)0.07
Today vs 20d1.30×
Avg vol (14d)7.37M
Avg vol (20d)6.82M
Avg $ vol (20d)97.96M
Market cap—
RS 3m (vs SPY)+9.09%
RS 6m (vs SPY)+58.03%
RS line new highNo
Trend template5/8
Technical rank91.2
1 week+6.25%
1 month+23.88%
3 months+25.76%
6 months+76.75%
1 year+74.16%
YTD+80.78%
P/E-5.43
P/B3.61
P/S33.09
P/FCF-5.66
EPS-3.81
Div yield—
ROE-66.46%
ROA-54.39%
Debt/Eq—
Current6.10
EV/EBITDA-4.88
Gross margin—
Net margin-609.85%
Rev growth16.92%
EPS growth20.49%
Price target21.06
Target upside31.42%
Analyst ratingBuy
Institutional90.10%
Ent. value2.1B
Revenue15.05M
Net income-96.23M
Gross profit—
Free cash flow-395.87M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out139.72M
Employees377
ListedFri, May 6, 2016
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank91.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.14
Support11.80
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NTLA
No recent disclosed trades by Congress in NTLA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NTLA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cohen Fred E Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Verwiel Frank Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Bhanji Muna Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
Keresty Georgia Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Keresty Georgia Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
GOODMAN JESSE Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
GOODMAN JESSE Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
CHASE WILLIAM J Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Verwiel Frank Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
Goff Brian Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
SEC filings
EDGAR filings in NTLA · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.